curacle co., ltd.
A clinical-stage biopharma developing drugs for intractable vascular diseases.
365270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7365270008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 효령로 23-1, 서울특별시
- Website:
- http://www.curacle.com/eng/main/
Description
Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-13 00:00 |
본점소재지변경
|
Korean | 5.5 KB | ||
| 2022-04-08 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 61.7 KB | ||
| 2022-03-30 00:00 |
정기주주총회결과
|
Korean | 22.4 KB | ||
| 2022-03-30 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.2 KB | ||
| 2022-03-22 00:00 |
감사보고서제출
|
Korean | 18.1 KB | ||
| 2022-03-22 00:00 |
사업보고서 (2021.12)
|
Korean | 436.8 KB | ||
| 2022-03-15 00:00 |
주주총회소집결의
|
Korean | 11.5 KB | ||
| 2022-03-15 00:00 |
주주총회소집공고
|
Korean | 110.3 KB | ||
| 2022-03-15 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.7 KB | ||
| 2022-02-24 00:00 |
투자판단관련주요경영사항(당뇨병성 신증 치료제 CU01-1001의 식품의약품안전처 3상 임상시험계획(IND) 신청 반려)
|
Korean | 8.6 KB | ||
| 2022-02-21 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2022-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.6 KB | ||
| 2022-02-14 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-01-10 00:00 |
투자판단관련주요경영사항(습성 연령관련 황반변성의 경구용 치료제 CU03-1001 임상 2a상 결과)
|
Korean | 19.2 KB | ||
| 2021-12-29 00:00 |
합병등종료보고서(자산양수도)
|
Korean | 12.0 KB |
Automate Your Workflow. Get a real-time feed of all curacle co., ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for curacle co., ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for curacle co., ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
